GROUP ONE TRADING, L.P. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187906. A total of 3 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$68,000
-66.8%
18,000
-55.2%
0.00%0.0%
Q4 2019$205,000
+15.8%
40,200
+14.9%
0.00%0.0%
Q3 2019$177,000
-32.2%
35,000
-17.3%
0.00%
-50.0%
Q2 2019$261,000
+163.6%
42,300
+98.6%
0.00%
+100.0%
Q1 2019$99,000
-65.7%
21,300
-69.1%
0.00%
-66.7%
Q4 2018$289,000
-55.5%
68,900
-33.4%
0.00%
-40.0%
Q3 2018$649,000
-35.1%
103,500
-16.8%
0.01%
-44.4%
Q2 2018$1,000,000
-19.1%
124,400
-24.9%
0.01%
-25.0%
Q1 2018$1,236,000
+802.2%
165,700
+620.4%
0.01%
+1100.0%
Q4 2017$137,000
+12.3%
23,000
+38.6%
0.00%0.0%
Q3 2017$122,000
+76.8%
16,600
+62.7%
0.00%0.0%
Q2 2017$69,000
-92.2%
10,200
-89.1%
0.00%
-90.0%
Q1 2017$887,000
+178.9%
94,000
+155.4%
0.01%
+233.3%
Q4 2016$318,000
+6.0%
36,800
-22.4%
0.00%0.0%
Q3 2016$300,000
+316.7%
47,400
+177.2%
0.00%
+200.0%
Q2 2016$72,000
-32.7%
17,100
-1.7%
0.00%0.0%
Q4 2015$107,000
-37.1%
17,400
-41.6%
0.00%
-50.0%
Q3 2015$170,000
-4.5%
29,800
+24.7%
0.00%0.0%
Q2 2015$178,000
+2.9%
23,900
-17.6%
0.00%
-33.3%
Q1 2015$173,000
-36.2%
29,000
-19.2%
0.00%
-25.0%
Q4 2014$271,000
+146.4%
35,900
+69.3%
0.00%
+100.0%
Q3 2014$110,000
-8.3%
21,200
-24.0%
0.00%0.0%
Q2 2014$120,000
-26.8%
27,900
-30.4%
0.00%
-33.3%
Q1 2014$164,000
-1.2%
40,100
+28.9%
0.00%0.0%
Q4 2013$166,000
+1744.4%
31,100
+1729.4%
0.00%
Q3 2013$9,000
+28.6%
1,700
+13.3%
0.00%
Q2 2013$7,0001,5000.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 47,400$300,0000.00%
SIMPLEX TRADING, LLC 49$1,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders